Press releases | Private Equity & Financial Sponsors, Tax |

Travers Smith advise management on the sale of LGC from KKR to Cinven and Astorg

Overview

Travers Smith LLP has advised the management team of LGC in relation to the acquisition of LGC by a consortium led by Cinven and Astorg, from KKR and management. Closing of the transaction is subject to customary regulatory approvals. 

LGC provides a comprehensive range of measurement tools, proficiency testing schemes, supply chain assurance standards and specialty genomics reagents underpinned by leading analytical and measurement science capabilities. Its scientific tools and solutions form an essential part of its customers’ quality assurance procedures and enable organisations to develop and commercialise new scientific products and advance research. The company serves customers across a number of end markets, including human healthcare, agri-food and the environment. LGC has its headquarters near London and employs over 3,200 employees across 22 countries.

The Travers Smith team was led by Private Equity and Financial Sponsors partner Adam Orr, assisted by associates Richard Hornshaw, James Ravden and Shannon Anstee. Tax advice was provided by partner Russell Warren and associate Kaleem Khan.

The Travers Smith team has a long-standing relationship with LGC, having acted for management when KKR acquired the business in 2015.

KKR was advised by Simpson Thacher and the consortium was advised by Latham & Watkins.